Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

SABCS 2008

10 - 14 Dec 2008
Videos
Reductions in breast density predict potential benefit of tamoxifen
Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology...
Reductions in breast density predict potential benefit of tamoxifen ( Dr Jack Cuzick - Head of Cancer Research UK Centre for Epidemiology, Mathematics and Statistics, London )
11 Mar 2009
Use of written forms doubles breast cancer detection rate
Dr William Goodson - Senior Clinical Research Scientist, California Pacific...
Use of written forms doubles breast cancer detection rate ( Dr William Goodson - Senior Clinical Research Scientist, California Pacific Medical Center Research Institute )
11 Mar 2009
Breast cancer patients may have better option to reduce oestrogen levels
Dr Stephen Jones - Director of US Oncology Research Inc, Texas
Breast cancer patients may have better option to reduce oestrogen levels ( Dr Stephen Jones - Director of US Oncology Research Inc, Texas )
11 Mar 2009
Hormone supplements reduce death from breast cancer
Sarah Marshall - Epidemiologist, University of California, Irvine
Hormone supplements reduce death from breast cancer ( Sarah Marshall - Epidemiologist, University of California, Irvine )
11 Mar 2009
Zoledronic acid may have anti-tumour properties
Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield
Zoledronic acid may have anti-tumour properties ( Dr Robert Coleman - Professor of Medical Oncology, University of Sheffield )
11 Mar 2009
Herceptin Increases event-free survival in locally advanced HER2-postive breast...
Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan
Herceptin Increases event-free survival in locally advanced HER2-postive breast cancer ( Dr Luca Gianni - Director of Medical Oncology, National Cancer Institute, Milan )
11 Mar 2009
New genetic modelling improves screening for breast cancer
Dr Kathie Dalessandri - Physician Scientist at the University of California...
New genetic modelling improves screening for breast cancer ( Dr Kathie Dalessandri - Physician Scientist at the University of California, San Francisco )
11 Mar 2009
New biomarker predicts anthracycline response
Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University
New biomarker predicts anthracycline response ( Dr John Bartlett - Professor of Molecular Pathology, Edinburgh University )
11 Mar 2009
Continuing adjuvant tamoxifen leads to higher quality of life
Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center...
Continuing adjuvant tamoxifen leads to higher quality of life ( Dr Shozo Ohsumi - Chief of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan )
11 Mar 2009
BIG 1-98: Letrozole vs tamoxifen
Dr Alan Coates - School of Public Health, University of Sydney
BIG 1-98: Letrozole vs tamoxifen ( Dr Alan Coates - School of Public Health, University of Sydney )
11 Mar 2009
Poor prognosis on small, HER2 positive tumours
Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department...
Poor prognosis on small, HER2 positive tumours ( Dr Ana M. Gonzalez-Angula - Department of Breast Medical Oncology, Department of Systems Biology at the University of Texas M.D. Anderson Cancer Center )
9 Mar 2009
Predictive value of HER2 and topoisomerase II alpha in early breast cancer...
Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital
Predictive value of HER2 and topoisomerase II alpha in early breast cancer patients treated with CMF or anthracycline-based adjuvant therapy ( Dr Angelo Di Leo - Sandro Pitigliani Medical Oncology Unit, Prato Hospital )
9 Mar 2009
10 new genes increase risk of breast cancer
Professor Douglas Easton, Cancer Research UK Genetic Epidemiology Unit...
10 new genes increase risk of breast cancer ( Professor Douglas Easton, Cancer Research UK Genetic Epidemiology Unit, Cambridge University )
12 Jan 2009
Various molecular imaging devices for non-invasive assessment of protein...
Professor David R. Piwnica-Worms, Director of the Molecular Imaging Center...
Various molecular imaging devices for non-invasive assessment of protein function and gene-expression pathways ( Professor David R. Piwnica-Worms, Director of the Molecular Imaging Center, Washington University )
12 Jan 2009
Prophylactic surgery for BRCA1 and BRCA2 carriers
Dr. William Wood, Chairman of the Department of Surgery, Emory University...
Prophylactic surgery for BRCA1 and BRCA2 carriers ( Dr. William Wood, Chairman of the Department of Surgery, Emory University School of Medicine )
12 Jan 2009
Circulating tumour cells
Professor Klaus Pantel, University Medical Center Hamburg-Eppendorf
Circulating tumour cells ( Professor Klaus Pantel, University Medical Center Hamburg-Eppendorf )
12 Jan 2009
Molecular mechanisms of breast cancer tumours
Dr. Kornelia Polyak, Dana-Farber Cancer Institute
Molecular mechanisms of breast cancer tumours ( Dr. Kornelia Polyak, Dana-Farber Cancer Institute )
12 Jan 2009
Sentinel node biopsy and other breast cancer surgery techniques
Dr Michael Douek, Consultant General Surgeon, University College London
Sentinel node biopsy and other breast cancer surgery techniques ( Dr Michael Douek, Consultant General Surgeon, University College London )
12 Jan 2009
Breast cancer stem cell regulation
Professor Max Wicha, Director, University of Michigan Comprehensive Cancer...
Breast cancer stem cell regulation ( Professor Max Wicha, Director, University of Michigan Comprehensive Cancer Center )
12 Jan 2009
Clinical research needs better interpretation
Professor Aron Goldhirsch, Director of the Department of Medicine at the...
Clinical research needs better interpretation ( Professor Aron Goldhirsch, Director of the Department of Medicine at the European Institute of Oncology )
12 Jan 2009
Extrapolating info from clinical trials to individual patients
Professor Richard Gelber, Biostatistics and Computational Biology, Dana-Farber...
Extrapolating info from clinical trials to individual patients ( Professor Richard Gelber, Biostatistics and Computational Biology, Dana-Farber Cancer Institute )
12 Jan 2009
Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer...
Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the...
Tamoxifen vs Aromatase Inhibitors and highlights of San Antonio Breast Cancer Symposium ( Professor Mitch Dowsett, Professor of Biochemical Endocrinology at the Institute of Cancer Research )
9 Jan 2009
Professor José Baselga, ESMO and Professor Martine Piccart, BIG
IMPAKT Conference - Exclusive preview
Professor José Baselga, ESMO and Professor Martine Piccart, BIG ( IMPAKT Conference - Exclusive preview )
9 Jan 2009
Endoxifen levels in Breast Cancer patients and testing for CYP2D6
Dr John Hawse, Department of Biochemistry and Molecular Biology, Mayo Clinic...
Endoxifen levels in Breast Cancer patients and testing for CYP2D6 ( Dr John Hawse, Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine )
9 Jan 2009
Breast Cancer Cell Apoptosis
Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies...
Breast Cancer Cell Apoptosis ( Dr Anthony Letai, Assistant Professor of Medicine, Haematologic Malignancies, Dana-Farber Cancer Institute )
9 Jan 2009
New data from the BIG 1-98 breast cancer trial
Professor Henning Mouridsen, Copenhagen University Hospital
New data from the BIG 1-98 breast cancer trial ( Professor Henning Mouridsen, Copenhagen University Hospital )
23 Dec 2008

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation